Clinical Trials Directory

Trials / Sponsors / Talaris Therapeutics Inc.

Talaris Therapeutics Inc.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 1 / Phase 22021-11-24
TerminatedA Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
Transplanted Organ Rejection
Phase 32019-10-25
WithdrawnA Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients
Kidney Transplantation
Phase 22012-10-15
WithdrawnPhase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Anemia, Sickle Cell, Complex and Transfusion-dependent Hemoglobinopathies, Thalassemia
Phase 1 / Phase 22011-05-01
TerminatedPhase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
Hurler Syndrome (MPS I), Hurler-Scheie Syndrome, Hunter Syndrome (MPS II)
Phase 1 / Phase 22011-04-01
TerminatedInduction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion
Kidney Failure
Phase 22008-03-01
WithdrawnAllogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis
Multiple Sclerosis
Phase 1 / Phase 22007-07-01
CompletedPhase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Sickle Cell Disease
Phase 1 / Phase 22005-01-01
UnknownInduction of Donor Specific Tolerance in Recipients of Live Donor Kidney Allografts by Donor Stem Cell Infusio
Renal Failure
Phase 1 / Phase 22005-01-01
No Longer AvailableInduction of Donor-Specific Tolerance in Recipients of Live Donor Stem Cell Infusion (Compassionate Use)
Renal Failure
——
No Longer AvailableAllogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)
Metachromatic Leukodystrophy
——
No Longer AvailableSingle Patient Expanded Access Protocol: Metabolic Boost
Metachromatic Leukodystrophy
——